These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 481651)

  • 1. Platelet supportive care: immunological and clinical aspects.
    Brand A; van Leeuwen A; Niterink A; Langerak J; Eernisse JG; van Rood JJ
    Neth J Med; 1979; 22(4):133-7. PubMed ID: 481651
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological principles of transfusion of blood platelet and granulocyte concentrates].
    Zupańska B
    Acta Haematol Pol; 1979 Oct; 10(4):327-32. PubMed ID: 539356
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion of platelets and plasma products.
    Menitove JE; Aster RH
    Clin Haematol; 1983 Feb; 12(1):239-66. PubMed ID: 6340882
    [No Abstract]   [Full Text] [Related]  

  • 4. Supportive haemotherapy in bone marrow transplantation.
    Mayr WR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):455-8. PubMed ID: 2480289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in platelet transfusion therapy.
    Slichter SJ
    Annu Rev Med; 1980; 31():509-40. PubMed ID: 6994626
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of HLA-C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Tomasulo PA; Aster RH
    Transplant Proc; 1977 Dec; 9(4):1827-8. PubMed ID: 601843
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet replacement therapy: a clinical assessment.
    Hester JP; McCredie KB; Freireich EJ
    Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
    [No Abstract]   [Full Text] [Related]  

  • 9. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Testin J; Aster RH
    Transplant Proc; 1977 Dec; 9(4):1829-31. PubMed ID: 601844
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of the patient alloimmunized to platelets.
    Tomasulo PA; Doddridge D; Reynolds AW
    J Fla Med Assoc; 1984 Jun; 71(6):397-9. PubMed ID: 6544323
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractoriness to platelet transfusion following partial hepatectomy for hepatocellular carcinoma: report of two cases.
    Kaibori M; Nagahama T; Yokoigawa N; Yanagida H; Nakamoto H; Kitade H; Satoi S; Onishi S; Kwon AH; Kamiyama Y
    Hepatogastroenterology; 2003; 50(51):832-6. PubMed ID: 12828097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the HLA-system in clinical medicine.
    van Rood JJ
    Schweiz Med Wochenschr; 1993 Jan; 123(3):85-92. PubMed ID: 8426953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of platelet transfusions.
    Murphy MF; Waters AH
    Br J Haematol; 1985 Jul; 60(3):409-14. PubMed ID: 4015986
    [No Abstract]   [Full Text] [Related]  

  • 16. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes].
    Májský A; Fortýnová J; Vopatová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-matched platelets from unrelated donors in the supportive therapy of patients undergoing intensive haematologic treatment.
    Reali G; Avanzi G; Bacigalupo A; Barbanti M; Ghinatti C; Queirolo MA; Van Lint MT; Marmont A
    Haematologica; 1978 Oct; 63(5):575-85. PubMed ID: 107077
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological support of component blood transfusion therapy].
    Shablin VN; Serova LD; Abdulkadyrov KM; Mel'nikova VN
    Probl Gematol Pereliv Krovi; 1978 Aug; 23(8):3-7. PubMed ID: 683985
    [No Abstract]   [Full Text] [Related]  

  • 19. [The need of a registry of HLA-phenotyped platelet donors].
    Castro Izaguirre E; Muncunill Ribas J
    Med Clin (Barc); 1995 Nov; 105(18):696-9. PubMed ID: 8538251
    [No Abstract]   [Full Text] [Related]  

  • 20. [Survival of 51Cr homologous platelets and HLA compatibility (author's transl)].
    Fortýnová J; Májský A; Vopatová M
    Cas Lek Cesk; 1980 Sep; 119(38):1023-9. PubMed ID: 7471144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.